Literature DB >> 1467136

7-Alkoxyquinoline O-dealkylation by microsomes from human liver and placenta.

J Hakkola1, J Mäenpää, R T Mayer, S S Park, H V Gelboin, O Pelkonen.   

Abstract

1. The O-dealkylation of seven 7-alkoxyquinoline derivatives by human hepatic and placental microsomes and the effect of maternal cigarette smoking on placental 7-alkoxyquinoline metabolism was studied. 2. None of several monoclonal antibodies to isoenzymes of cytochrome P450 had a clear effect on metabolism of the compounds by liver microsomes. 3. Maternal cigarette smoking induced the O-dealkylation of all of the 7-alkoxyquinoline derivatives, being greatest for 7-butoxy- and 7-benzyloxyquinoline. 4. Placental 7-alkoxyquinoline metabolism induced by smoking was partially inhibited by the monoclonal antibody 1-7-1 raised against 3-methylcholanthrene-induced rat liver P450. 5. None of the 7-alkoxyquinoline O-dealkylations could be assigned specifically to any known P450 isoenzyme in human liver or placenta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1467136      PMCID: PMC1381470          DOI: 10.1111/j.1365-2125.1992.tb05650.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  21 in total

Review 1.  The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci.

Authors:  D W Nebert; D R Nelson; M Adesnik; M J Coon; R W Estabrook; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson; B Kemper
Journal:  DNA       Date:  1989 Jan-Feb

Review 2.  Characterization of human microsomal cytochrome P-450 enzymes.

Authors:  F P Guengerich
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

3.  Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse.

Authors:  H Raunio; J Valtonen; P Honkakoski; M A Lang; M Ståhlberg; M A Kairaluoma; A Rautio; M Pasanen; O Pelkonen
Journal:  Biochem Pharmacol       Date:  1990-12-01       Impact factor: 5.858

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 5.  Multiplicity of mammalian microsomal cytochromes P-45.

Authors:  A Y Lu; S B West
Journal:  Pharmacol Rev       Date:  1979-12       Impact factor: 25.468

6.  7-Alkoxyquinolines: new fluorescent substrates for cytochrome P450 monooxygenases.

Authors:  R T Mayer; K J Netter; F Heubel; B Hahnemann; A Buchheister; G K Mayer; M D Burke
Journal:  Biochem Pharmacol       Date:  1990-10-01       Impact factor: 5.858

7.  Immunochemical and molecular biological studies on human placental cigarette smoke-inducible cytochrome P-450-dependent monooxygenase activities.

Authors:  M Pasanen; T Haaparanta; M Sundin; P Sivonen; K Vakakangas; H Raunio; R Hines; J A Gustafsson; O Pelkonen
Journal:  Toxicology       Date:  1990-05-31       Impact factor: 4.221

8.  Phenotyping of cytochromes P-450 in human tissues with monoclonal antibodies.

Authors:  T Fujino; S S Park; D West; H V Gelboin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

9.  Differential expression and regulation of members of the cytochrome P450IA gene subfamily in human tissues.

Authors:  D Sesardic; M Pasanen; O Pelkonen; A R Boobis
Journal:  Carcinogenesis       Date:  1990-07       Impact factor: 4.944

Review 10.  The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.

Authors:  D W Nebert; D R Nelson; M J Coon; R W Estabrook; R Feyereisen; Y Fujii-Kuriyama; F J Gonzalez; F P Guengerich; I C Gunsalus; E F Johnson
Journal:  DNA Cell Biol       Date:  1991 Jan-Feb       Impact factor: 3.311

View more
  1 in total

1.  Selective serotonin reuptake inhibitors and theophylline metabolism in human liver microsomes: potent inhibition by fluvoxamine.

Authors:  B B Rasmussen; J Maënpää; O Pelkonen; S Loft; H E Poulsen; J Lykkesfeldt; K Brøsen
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.